Euglycemic Clamp Studies

Precision in Insulin Sensitivity Assessment

Navitas Life Sciences specializes in hyperinsulinemic euglycemic clamp studies, recognized as the gold standard for assessing insulin sensitivity in humans. This advanced euglycemic clamp technique involves maintaining steady blood glucose levels using a variable glucose infusion rate (GIR) to measure the glucose-lowering effect of biosimilar insulin compounds. Our expertise is backed by extensive resources, including state-of-the-art glucose analyzers, ECLIA analyzers, and highly sensitive triple quad mass spectrometers, ensuring precise and reliable outcomes. Additionally, we utilize validated methods for estimating insulin, its analogs, and metabolites, employing analytical platforms like ligand binding and chromatographic assays.

Your Trusted Partner for Euglycemic Clamp Studies.

Navitas Life Sciences offers a strategic advantage for biosimilar insulin clinical research, providing dedicated teams to manage every aspect of the trial. With deep domain expertise, we overcome the complexities of large molecule insulin formulations, offering tailored solutions to mitigate risks and streamline development. As your reliable partner, we combine intelligent monitoring solutions, robust data analysis, and comprehensive regulatory support to help your anti-diabetic therapies reach the market faster. Powering Possibilities in euglycemic insulin clamp studies to deliver excellence and accelerate success.

Image

Highlights of Our Euglycemic Clamp Study Support Include:

Vast Expertise
Vast Expertise
Proficiency in ensuring precise execution of the euglycemic glucose clamp technique.
Patient Safety
Patient Safety
Continuous and thorough safety monitoring of subjects throughout the study.
Advanced Infrastructure
Advanced Infrastructure
Extensive instrumentation for analysis, including glucose analyzers, ECLIA analyzers, and highly sensitive triple quad mass spectrometers.
Validated Methods
Validated Methods
Established methods for the accurate estimation of insulin, its analogs, and metabolites.
Diverse Analytical Platforms
Diverse Analytical Platforms
Access to robust analytical platforms such as ligand binding assays and chromatographic assays.
Rigorous Data Analysis
Rigorous Data Analysis
Comprehensive and meticulous data analysis to ensure high-quality results.
Insulin Expertise
Insulin Expertise
Specialized knowledge to address the complexities of large-molecule, water-soluble insulin.

Stellar Euglycemic Clamp Studies Catered to your Compound’s Unique needs

Navitas Life Sciences is a globally known center for clinical research, with the unique capability to structure resources based on the needs of the compound.  With us, you get a dedicated team to coordinate every aspect of your clinical trial, using intelligent monitoring solutions, effective project design support and guidance through the evolving regulatory landscape to deliver high quality outcomes that advance your product to the market faster.

Image

Brochure

Alt Text

Euglycemic clamp studies

Find out how Navitas Life Sciences has the capabilities and resources to enable biosimilars companies to bring effective anti-diabetic therapies to the market quickly and safely.

Article

Alt Text

Intelligent Virtual Clinical Trials

Published in: PharmaFocus Asia
Explore how Artificial Intelligence (AI) has provided the much-needed impetus for transforming clinical trials into the virtual sphere for greater efficiency.

Article

Alt Text

Current Status of Biosimilars and Their Impact on Pharmacovigilance

Published in: PharmExec.com
As the market for biosimilars expands, a nuanced approach is needed to balance cost considerations with patient safety and pharmacovigilance efforts.

Extensive Experience in Managing Efficient Euglycemic Clamp Studies

Image

Gain the Navitas Life Sciences Edge

Holistic Approach

Holistic Approach

Balancing scientific rigor with cost-effectiveness.
8 Offices World Wide

8 Offices World Wide

Including 4 delivery centers across the globe.

Specialized Focus

Specialized Focus

Expertise in vulnerable populations and niche areas.
Strategic Support

Strategic Support

From TPP to regulatory compliance, we cover all bases.
Expert Team

Expert Team

Medical monitors with rich academic and industry experience.

BLOGS

Alt Text

Diabetes Clinical Trials

At Navitas Lifesciences, we are committed to bridging these gaps by managing efficient diabetes clinical trials that bring innovative treatments to those who need them most.
Alt Text

Supporting Diabetes Research through State-of-the-Art Euglycemic Clamp Studies

This blog highlights our unique capabilities in managing efficient euglycemic clamp studies, showcasing how we expedite the development of biosimilar insulin and propel the evolution of diabetic therapies.
Alt Text

Expert Insights about Care and How we Manage Efficient Euglycemic Clamp Studies 

Find out how we support your biosimilar study with the highest level of compliance to regulatory requirements, leveraging our expertise and infrastructure to ensure that your biosimilar Insulin product is launched quickly.  

Get in touch

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us